ID_KLBF 2025-03-31 Q1

Status: OK; Currency: IDR; Amounts unit: millions; Forms: ✓ ✓ ✓

Report published: Not stored for this period — set financial_report_date on the row (EDGAR filingDate, KASE change_date, or manual_catalog).

To recalculate statement detection and previews from the PDF, use this link The default link runs in the background: a status panel shows phase, elapsed time, rough ETA, CUDA vs CPU, and OOM hints, then loads the finished report. Heavy mode with refresh does this automatically so reverse proxies do not return 502. Add &sync=1 only for one long blocking request (not recommended). You can use ?refresh=1, ?recalc=1, ?nocache=1, or ?recompute=1 on the URL. (block in the browser until done: synchronous refresh)

Metric mapping (value → extracted evidence)

Metric values use dashboard units where applicable; evidence is the stored snippet from the PDF text layer or OCR used during extraction.

Metric	Value	Evidence / page extract
Revenue	8 845.37	Row: revenue (mln IDR, batch apply) · dashboard=8,845.368 mln — [DeepSeek] revenue (mln IDR, batch apply)
Operating profit	1 429.26	—
D&A	181.3	Row: Penyusutan (segment note) (CF unknown method; scale x1.0; mln) · dashboard=181.302 mln — [DeepSeek/line] Penyusutan (segment note) (CF unknown method; scale x1.0; mln)
EBITDA	1 610.57	Row: operating_profit + da (mln) · dashboard=1,610.565 mln — operating_profit + da (mln)
Net profit	1 076.77	Row: net_profit (mln IDR, batch apply) · dashboard=1,076.772 mln — [DeepSeek] net_profit (mln IDR, batch apply)
Cash	4 542.83	Row: cash (mln IDR, batch apply) · dashboard=4,542.834 mln — [DeepSeek] cash (mln IDR, batch apply)
Debt short	311.87	Row: debt_short (mln IDR, batch apply) · dashboard=311.866 mln — [DeepSeek] debt_short (mln IDR, batch apply)
Debt long	222.33	Row: debt_long (mln IDR, batch apply) · dashboard=222.329 mln — [DeepSeek] debt_long (mln IDR, batch apply)
Net debt	-4 008.64	Components: short debt 311.87 + long debt 222.33 + other financial liab. 0 + NCI 0 − cash 4 542.83 = net debt -4 008.64.Row: net_debt (mln IDR, batch apply) · dashboard=-4,008.638 mln — [DeepSeek] net_debt (mln IDR, batch apply)
Operating CF	344.56	—
Investing CF	-118.66	—
Assets	30 579.06	Row: total_assets (mln IDR, batch apply) · dashboard=30,579.056 mln — [DeepSeek] total_assets (mln IDR, batch apply)
Equity	25 360.65	Row: total_equity (mln IDR, batch apply) · dashboard=25,360.650 mln — [DeepSeek] total_equity (mln IDR, batch apply)

Consistency checks · Warnings

✓	Balance sheet identity (A = L + E)	Implied total liabilities (TA − TE) = 5,218; known debt components fit within that envelope.
✓	Net debt formula	net_debt -4,009 matches \|debt_short\|+\|debt_long\|+\|other\|+\|NCI\|−\|cash\| = -4,009.
✓	EBITDA = OP + D&A	EBITDA (1,611) ≈ OP (1,429) + D&A (181) = 1,611.
✓	Net profit vs operating profit	Net profit (1,077) sits within a plausible band vs operating profit (1,429).
✓	Cash ≤ total assets	Cash (4,543) ≤ total assets (30,579).
⚠	Debt step-change vs prior period	Total interest-bearing debt fell 100% vs prior period (561,787 → 534). Financing cash flow not extracted — can't verify the move was real (could be an OCR miss of a major debt line).

Statement pages (discovery)

Statement previews & reconstructed tables

Form	Pages
P&L	5, 6
BS	7, 8
CF	9

Highlights Yellow row = matched stored evidence label; orange cell = exact number used for that metric (hover row for details). Revenue Operating profit D&A EBITDA Net profit cash debt_short debt_long Assets Equity Operating CF Investing CF

Green / amber / red bars on the label column mark subtotal rows where summed detail lines match the reported total (heuristic). The table under each reconstructed grid lists every check (Σ detail vs reported, status).

P&L

Metric	Value
Revenue	8 845.37
Operating profit	1 429.26
EBITDA	1 610.57
Net profit	1 076.77
D&A	181.3

P&L — PDF page 5

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 5 (33 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language.
2	PT KALBE FARMA Tbk DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
4	Tanggal 31 Maret 2025 (Belum Diaudit) OF FINANCIAL POSITION
5	(Disajikan dalam Rupiah, kecuali dinyatakan lain) As of March 31, 2025 (Unaudited)
6	(Expressed in Rupiah, unless otherwise stated)
7	ASET
8	ASET LANCAR
9	Kas dan setara kas	4542833756938	2.4	4723293839405
10	Piutang usaha	0	2.3
11	Pihak ketiga, neto	5956071898914	0	4811900617646
12	Pihak berelasi	55980775130	8	52647252874
13	Piutang lain-lain	0	2.6
14	Pihak ketiga	196291960771	0	142753485952
15	Pihak berelasi	483900995	8000000000	5859160695
16	Aset keuangan lancar lainnya	145687966826	2.7	143138050660
17	Persediaan neto	6560760533339	2.3	6501631203212
18	Pajak dibayar di muka	484730667504	2.3	454003891826
19	Biaya dibayar di muka	117136878515	10	45252777570
20	Aset lancar lainnya	328918784769	11	307188147884
21	Total Aset Lancar	18395897123701	0	17187668427724
22	ASET TIDAK LANCAR
23	Aset keuangan tidak lancar lainnya	316198023443	2.12	311003484224
24	Investasi pada entitas asosiasi	222584608004	2.3	206614991397
25	Aset pajak tangguhan; neto	130825358759	2.3	120348768765
26	Tagihan restitusi pajak	357300382597	2.3	406189362151
27	Aset tetap neto	8233164163172	2.3	269375706540
28	Aset takberwujud, neto	2305627408864	2.3	2315733488492
29	Aset hak-guna neto	111506285505	2.3	103660396585
30	Aset tidak lancar lainnya	505952766436	2.3	509133272317
31	Total Aset Tidak Lancar	12183158996780	0	12242059470471
32	TOTAL ASET	30579056120481	0	29429727898195

P&L — PDF page 6

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 6 (41 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language.
2	PT KALBE FARMA Tbk: DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
4	(lanjutan) OF FINANCIAL POSITION (continued)
5	Tanggal 31 Maret 2025 (Belum Diaudit) As of March 31, 2025 (Unaudited)
6	(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
7	LIABILITAS
8	LIABILITAS JANGKA PENDEK
9	Utang bank jangka pendek	239250000000	2.18	269100000000
10	Utang usaha	0	2.2
11	Pihak ketiga	2064725404520	0	1810744681638
12	Pihak berelasi	104326732788	8	81424796241
13	Utang lain-lain	0	2.21
14	Pihak ketiga	825678355250	0	931970929981
15	Pihak berelasi	2655221090	8	297963762
16	Beban akrual	647095928544	2.22	600216924626
17	Liabilitas imbalan kerja
18	jangka pendek	92120772704	2	172293437898
19	Utang pajak	486051186946	2.3	248818958693
20	Bagian jangka pendek dari:
21	Utang bank	54408220243	2.18	53006372373
22	Liabilitas sewa	17378245037	2.3	17068218887
23	Utang pembiayaan	829592138	2	807203970
24	Total Liabilitas Jangka Pendek	4534519659260	0	4185749488069
25	LIABILITAS JANGKA PANJANG
26	Pinjaman jangka panjang;
27	setelah dikurangi dengan
28	bagian jangka pendek:
29	Utang bank	54546250001	2.18	65455500000
30	Liabilitas sewa	30953192685	2.3	25063249412
31	Utang pembiayaan	342075387	2	1558060348
32	Pinjaman konversi	135188589954	2.19	129528764238
33	Liabilitas pajak tangguhan, neto	84693141687	2.3	63080063097
34	Liabilitas imbalan kerja
35	jangka panjang	372615316890	2.3	368359138545
36	Utang lain-Iain jangka panjang	0	2
37	Pihak ketiga	4048250000	0
38	Pihak berelasi	499824000	8	499824000
39	Total Liabilitas Jangka Panjang	683886640604	0	653544599640
40	TOTAL LIABILITAS	5218406299864	0	4839294087709

Metric	Value
Cash	4 542.83
Debt Short	311.87
Debt Long	222.33
Assets	30 579.06
Equity	25 360.65
Net debt	-4 008.64

BS — PDF page 7

Camelot table (pages 7, primary page 7).

#	Joined label	Line item	Column 2	Column 3	Equity Attributable to → Owners o…
0	Diatribusikan kepada Equity Attributable to	Diatribusikan kepada			Equity Attributable to
1	Pemilik Entitas Induk Owners of the Parent Company	Pemilik Entitas Induk			Owners of the Parent Company
2	Modal saham - nilai nominal Share capital - Rp10 par value	Modal saham - nilai nominal			Share capital - Rp10 par value
3	Rp10 per saham per share	Rp10 per saham			per share
4	Modal dasar - Authorized -	Modal dasar -			Authorized -
5	85.000.000.000 saham 85,000,000,000 shares	85.000.000.000 saham			85,000,000,000 shares
6	Modal ditempatkan dan disetor Issued and fully paid -	Modal ditempatkan dan disetor			Issued and fully paid -
7	penuh - 46.875.122.110 saham 468.751.221.100 24 468.751.221.100 46,875,122,110 shares	penuh - 46.875.122.110 saham	468.751.221.100	24	468.751.221.100 46,875,122,110 shares
8	Tambahan modal disetor, neto (29.060.429.594) 2,25 (29.060.429.594) Additional paid-in capital, net	Tambahan modal disetor, neto	(29.060.429.594)	2,25	(29.060.429.594) Additional paid-in capital, net
9	Selisih transaksi dengan Differences arising from transaction	Selisih transaksi dengan			Differences arising from transaction
10	kepentingan non-pengendali 373.937.488.809 2,26 373.937.488.809 with non-controlling interests	kepentingan non-pengendali	373.937.488.809	2,26	373.937.488.809 with non-controlling interests
11	Saldo laba Retained earnings	Saldo laba			Retained earnings
12	Telah ditentukan penggunaannya 371.687.456.205 24 371.687.456.205 Appropriated	Telah ditentukan penggunaannya	371.687.456.205	24	371.687.456.205 Appropriated
13	Belum ditentukan penggunaannya 24.018.563.688.305 24 22.941.791.293.036 Unappropriated	Belum ditentukan penggunaannya	24.018.563.688.305	24 22.941.791.293.036	Unappropriated
14	Saham treasuri - Treasury stock -	Saham treasuri -			Treasury stock -
15	1.229.597.200 saham pada 1,229,597,200 shares as of	1.229.597.200 saham pada			1,229,597,200 shares as of
16	31 Maret 2025 dan March 31, 2025 and	31 Maret 2025 dan			March 31, 2025 and
17	923.657.900 saham pada 923,657,900 shares as of	923.657.900 saham pada			923,657,900 shares as of
18	31 Desember 2024 (1.829.135.800.499) 2,24 (1.462.394.857.000) December 31, 2024	31 Desember 2024	(1.829.135.800.499)	2,24 (1.462.394.857.000)	December 31, 2024
19	Penghasilan komprehensif lain Other comprehensive income	Penghasilan komprehensif lain			Other comprehensive income
20	Selisih kurs atas penjabaran Differences arising from foreign	Selisih kurs atas penjabaran			Differences arising from foreign
21	laporan keuangan 94.847.048.598 2 81.662.254.669 currency translation	laporan keuangan	94.847.048.598	2	81.662.254.669 currency translation
22	Laba belum direalisasi Unrealized gain on	Laba belum direalisasi			Unrealized gain on
23	dari aset keuangan tersedia available-for-sale	dari aset keuangan tersedia			available-for-sale

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

BS — PDF page 8

Camelot table (pages 8, primary page 8).

#	Joined label	Line item	2025	2024	NET SALES → COST OF GOODS SOLD
0	Period Ended March 31		Period Ended March 31
1	Catatan/		Catatan/
2	2025 Notes 2024		2025 Notes	2024
3	PENJUALAN NETO 8.845.368.157.355 2,8,28,29 8.363.028.651.272 NET SALES	PENJUALAN NETO	8.845.368.157.355 2,8,28,29	8.363.028.651.272	NET SALES
4	BEBAN POKOK PENJUALAN (5.169.098.276.338) 2,8,28,30 (5.041.736.437.452) COST OF GOODS SOLD	BEBAN POKOK PENJUALAN	(5.169.098.276.338) 2,8,28,30	(5.041.736.437.452)	COST OF GOODS SOLD
5	LABA BRUTO 3.676.269.881.017 3.321.292.213.820 GROSS PROFIT	LABA BRUTO	3.676.269.881.017	3.321.292.213.820	GROSS PROFIT
6	Beban penjualan (1.815.016.744.801) 2,28,31 (1.653.202.735.065) Selling expenses	Beban penjualan	(1.815.016.744.801) 2,28,31	(1.653.202.735.065)	Selling expenses
7	General and administrative				General and administrative
8	Beban umum dan administrasi (376.532.128.804) 2,28,32 (358.086.560.488) expenses	Beban umum dan administrasi	(376.532.128.804) 2,28,32	(358.086.560.488)	expenses
9	Beban penelitian Research and development	Beban penelitian			Research and development
10	dan pengembangan (103.543.099.911) 2,28,33 (90.061.550.508) expenses	dan pengembangan	(103.543.099.911) 2,28,33	(90.061.550.508)	expenses
11	Pendapatan operasi lainnya 9.286.384.687 2,8,28,37 24.649.890.625 Other operating income	Pendapatan operasi lainnya	9.286.384.687 2,8,28,37	24.649.890.625	Other operating income
12	Beban operasi lainnya (14.587.384.060) 2,28,36 (10.722.444.088) Other operating expenses	Beban operasi lainnya	(14.587.384.060) 2,28,36	(10.722.444.088)	Other operating expenses
13	Penghasilan bunga 50.443.996.704 2,28,35 40.147.195.124 Interest income	Penghasilan bunga	50.443.996.704 2,28,35	40.147.195.124	Interest income
14	Interest expense and				Interest expense and
15	Beban bunga dan keuangan (13.026.718.774) 2,28,34 (15.044.162.819) financial charges	Beban bunga dan keuangan	(13.026.718.774) 2,28,34	(15.044.162.819)	financial charges
16	Bagian atas laba Share in gain of the	Bagian atas laba			Share in gain of the
17	entitas asosiasi, neto 15.969.616.607 2,13,23,28 8.602.098.250 associates, net	entitas asosiasi, neto	15.969.616.607 2,13,23,28	8.602.098.250	associates, net
18	LABA SEBELUM BEBAN INCOME BEFORE	LABA SEBELUM BEBAN			INCOME BEFORE
19	PAJAK PENGHASILAN 1.429.263.802.665 1.267.573.944.851 INCOME TAX EXPENSE	PAJAK PENGHASILAN	1.429.263.802.665	1.267.573.944.851	INCOME TAX EXPENSE
20	BEBAN PAJAK PENGHASILAN (318.805.978.265) 2,3,23,28 (279.996.230.340) INCOME TAX EXPENSE	BEBAN PAJAK PENGHASILAN	(318.805.978.265) 2,3,23,28	(279.996.230.340)	INCOME TAX EXPENSE
21	LABA PERIODE BERJALAN 1.110.457.824.400 987.577.714.511 INCOME FOR THE PERIOD	LABA PERIODE BERJALAN	1.110.457.824.400	987.577.714.511	INCOME FOR THE PERIOD
22	PENGHASILAN OTHER COMPREHENSIVE	PENGHASILAN			OTHER COMPREHENSIVE
23	KOMPREHENSIF LAIN INCOME	KOMPREHENSIF LAIN			INCOME
24	Pos yang tidak akan direklasifikasi Item that will be not reclassified	Pos yang tidak akan direklasifikasi			Item that will be not reclassified
25	ke laba rugi: - - to profit or loss:	ke laba rugi:	-	-	to profit or loss:
26	Pos-pos yang akan direklasifikasi Items that will be reclassified	Pos-pos yang akan direklasifikasi			Items that will be reclassified
27	ke laba rugi: to profit or loss:	ke laba rugi:			to profit or loss:

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

Metric	Value
Operating CF	344.56
Investing CF	-118.66

CF — PDF page 9

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 9 (22 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language.
2	PT KALBE FARMA Tbk: DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk: AND ITS SUBSIDIARIES
3	LAPORAN LABA RUGI DAN PENGHASILAN CONSOLIDATED STATEMENT OF PROFIT OR LOSS
4	KOMPREHENSIF LAIN KONSOLIDASIAN (lanjutan) AND OTHER COMPREHENSIVE INCOME
5	Untuk Periode yang Berakhir pada Tanggal (continued)
6	31 Maret 2025 (Belum Diaudit) For the Period Ended March 31, 2025 (Unaudited)
7	(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
8	Laba Periode Berjalan Yang
9	Dapat Diatribusikan Kepada:
10	Pemilik entitas induk	1076772395269	2.28	957560071712
11	Kepentingan non-pengendali	33685429131	2.28	30017642799
12	Total	1110457824400	0	987577714511
13	Total Laba Komprehensif
14	Periode Berjalan Yang Dapat
15	Diatribusikan Kepada:
16	Pemilik entitas induk	1094719644583	0	962803734999
17	Kepentingan non-pengendali	43614336598	2.28	30017642799
18	Total	1138333981181	0	992821377798
19	Laba per Saham Dasar
20	Yang Dapat Diatribusikan
21	kepada Pemilik Entitas Induk	23.57	2.24	20.7

ID_KLBF 2025-03-31 Q1 — report review

Metric mapping (value → extracted evidence)

Consistency checks · Warnings

Statement pages (discovery)

Statement previews & reconstructed tables

P&L

BS

CF

Formulas used